HK1044900A1 - 用於治療神經病或神經精神疾病的方法 - Google Patents

用於治療神經病或神經精神疾病的方法

Info

Publication number
HK1044900A1
HK1044900A1 HK02106650.6A HK02106650A HK1044900A1 HK 1044900 A1 HK1044900 A1 HK 1044900A1 HK 02106650 A HK02106650 A HK 02106650A HK 1044900 A1 HK1044900 A1 HK 1044900A1
Authority
HK
Hong Kong
Prior art keywords
neurological
treatment
neuropsychiatric disorders
neuropsychiatric
disorders
Prior art date
Application number
HK02106650.6A
Other languages
English (en)
Inventor
Lynn Willis Gregory
Original Assignee
Clarencew Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO2745A external-priority patent/AUPO274596A0/en
Priority claimed from US09/285,859 external-priority patent/US6310085B1/en
Application filed by Clarencew Pty Ltd filed Critical Clarencew Pty Ltd
Publication of HK1044900A1 publication Critical patent/HK1044900A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02106650.6A 1996-10-04 2002-09-10 用於治療神經病或神經精神疾病的方法 HK1044900A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO2745A AUPO274596A0 (en) 1996-10-04 1996-10-04 Method for the treatment of neurological or neuropsychiatric disorders
US09/285,859 US6310085B1 (en) 1997-10-03 1999-04-02 Method for the treatment of neurological or neuropsychiatric disorders
PCT/AU2000/000275 WO2000059504A1 (en) 1996-10-04 2000-03-31 Method for the treatment of neurological or neuropsychiatric disorders

Publications (1)

Publication Number Publication Date
HK1044900A1 true HK1044900A1 (zh) 2002-11-08

Family

ID=42341459

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106650.6A HK1044900A1 (zh) 1996-10-04 2002-09-10 用於治療神經病或神經精神疾病的方法

Country Status (3)

Country Link
KR (1) KR20010112372A (zh)
HK (1) HK1044900A1 (zh)
IL (1) IL145696A (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102407182B1 (ko) * 2011-05-31 2022-06-10 클라렌슈 피티와이 리미티드 광선 요법 장치

Also Published As

Publication number Publication date
IL145696A (en) 2006-08-20
KR20010112372A (ko) 2001-12-20

Similar Documents

Publication Publication Date Title
IL133800A0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
HUP0100815A3 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
GB2305605B (en) Pipecolic acid derivatives for the treatment of neurological disorders
HUP0001237A3 (en) Methods for treating vascular disorders
IL145696A0 (en) Method for the treatment of neurological or neuropsychiatric disorders
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
EP0946485A4 (en) METHOD FOR TREATING DERMATOLOGICAL DISEASES
IL134289A0 (en) Methods for treating neurological deficits
IL141263A0 (en) Methods for treatment of neurological disorders
PL345338A1 (en) Method for the treatment of insomnia
EP0820467A4 (en) METHODS OF TREATING EYE DISORDERS
EP0729361A4 (en) METHOD FOR TREATING NEUROLOGICAL DISEASES
GB9908175D0 (en) Method of treating neurological disorders
EP0918767A4 (en) PHARMACEUTICAL PRODUCT FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS
AU1578295A (en) Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
EP1039883A4 (en) METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
PL332313A1 (en) Application of benzopyranoles in treatment of neurological disorders
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
EP0679397A3 (de) Verwendung von substituierten Aminen zur Behandlung von Hirnleistungsstörungen.
GR950100091A (en) Method for the treatment of plants.
EP0981357A4 (en) METHODS AND COMPOSITIONS APPLICABLE TO THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS
HK1044900A1 (zh) 用於治療神經病或神經精神疾病的方法
EP0979234A4 (en) METHODS AND COMPOSITIONS APPLICABLE TO THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS
ZA985818B (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
PT1011678E (pt) Utilização de mecamilamina para o tratamento de perturbações neuropsiquiátricas responsivas à nicotina.